<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The present experiment was undertaken to study what types of human <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> are responsive to the antiproliferative effects of <z:chebi fb="0" ids="45906">suramin</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>The human malignant cells used were as follows: <z:e sem="disease" ids="C0302592" disease_type="Neoplastic Process" abbrv="">cervical cancer</z:e> (HeLa), mammary <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> (MCF-7), <z:e sem="disease" ids="C0005684" disease_type="Neoplastic Process" abbrv="">bladder cancer</z:e> (EJ), <z:e sem="disease" ids="C0019204" disease_type="Neoplastic Process" abbrv="">hepatoma</z:e> (HuH-7, PLC/PRF/5), embryonal <z:mp ids='MP_0002038'>carcinoma</z:mp> (PA-1), in vitro transformed fibroblasts (KMST-6, SUSM-1, VA-13), five <z:mp ids='MP_0009440'>myeloma</z:mp> cell lines (KMM-1, KMS-5, KMS-11, KMS-12, RPMI 8226), Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (Raji), <z:hpo ids='HP_0004836'>acute promyelocytic leukemia</z:hpo> (<z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>-60), <z:hpo ids='HP_0011010'>chronic</z:hpo> myelocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (K562), Epstein-Barr virus nuclear antigen positive lymphoblastoid cells (KMS-9) </plain></SENT>
<SENT sid="2" pm="."><plain>The cells were treated with 25 to 100 micrograms/ml <z:chebi fb="0" ids="45906">suramin</z:chebi> for 72h </plain></SENT>
<SENT sid="3" pm="."><plain>Proliferation of HuH-7 and two human <z:mp ids='MP_0009440'>myeloma</z:mp> cells (KMS-11 and KMS-12) was remarkably inhibited, and that of PA-1, PLC/PRF/5, KMST-6, two other <z:mp ids='MP_0009440'>myeloma</z:mp> cell lines (KMM-1 and KMS-5), Raji and <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>-60, was moderately inhibited </plain></SENT>
<SENT sid="4" pm="."><plain>In order to confirm part of the results obtained from in vitro experiments, in vivo experiments were also undertaken </plain></SENT>
<SENT sid="5" pm="."><plain>The growth of HuH-7 cells transplanted subcutaneously into <z:mp ids='MP_0003815'>nude</z:mp> mice was significantly suppressed by intravenous injection of <z:chebi fb="0" ids="45906">suramin</z:chebi> </plain></SENT>
<SENT sid="6" pm="."><plain>We discussed the possibility that certain types of human <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>, the growth of which seemed to be more or less dependent on <z:chebi fb="1" ids="15841">polypeptide</z:chebi> growth factors, might be sensitive to the antiproliferative effects of <z:chebi fb="0" ids="45906">suramin</z:chebi> </plain></SENT>
</text></document>